Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2025-12-25 @ 2:56 PM
Study NCT ID:
NCT00280150
Status:
COMPLETED
Last Update Posted:
2017-06-19
First Post:
2006-01-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
None
Primary Completion Date:
2012-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-19
First Submit QC Date:
None
Study First Post Date:
2006-01-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-24
Results First Submit QC Date:
None
Results First Post Date:
2017-06-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-19
Last Update Post Date:
2017-06-19
Last Update Post Date Type:
ACTUAL